Skip to main content
Log in

Cytogenetic analysis of a malignant triton tumour by comparative genomic hybridization (CGH) and review of the literature

  • Short Communication
  • Published:
European Archives of Oto-Rhino-Laryngology Aims and scope Submit manuscript

Abstract

Malignant triton tumour (MTT) is a rare, highly malignant neoplasm, characterized by a mixture of cells with nerve sheath and skeletal muscle differentiation. Cytogenetic analyses of this neoplasm are rare to date and none comparative genomic hybridisation (CGH) analysis has been published. In the present study we report about the genomic imbalances of a MMT analysed by CGH, in a 39-year-old male patient without neurofibromatosis. We observed the amplifications at chromosomal location 1p, 6p, 16p, 16q, 17p, 17q, 19p, 19q, 20p, and 22q. Comparing our results with those of previous studies, we found evidence for recurrent genomic aberrations at the chromosomes 1, 16, 17, 19, and 22 suggesting the involvement of several oncogenes in the genesis of MTT.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

References

  1. Weiss SW, Goldblum JR (2007) Enzinger and weiss’s soft tissue tumors, 5th edn. Mosby, Missouri

    Google Scholar 

  2. Ducatman BS, Scheithauer BW (1984) Malignant peripheral nerve sheath tumors with divergent differentiation. Cancer 54(6):1049–1057

    Article  PubMed  CAS  Google Scholar 

  3. Brooks JS, Freeman M, Enterline HT (1985) Malignant “triton” tumors: natural history and immunohistochemistry of nine cases with literature review. Cancer 55(11):2543–2549

    Article  PubMed  CAS  Google Scholar 

  4. Travis JA, Sandberg AA, Neff JR, Bridge JA (1994) Cytogenetic findings in malignant triton tumor. Genes Chromosomes Cancer 9:1–7

    Article  PubMed  CAS  Google Scholar 

  5. McComb EN, McComb RD, DeBoner JM, Neff JR, Bridge JA (1996) Cytogenetic analysis of a malignant triton tumor and a malignant peripheral nerve sheath tumor and a review of literature. Cancer Genet Cytogenet 91:8–12

    Article  PubMed  CAS  Google Scholar 

  6. Henning Y, Löschke S, Katenkamp D, Bartnitzke S, Bullerdiek J (2000) A malignant triton tumor with an unbalanced translocation (1;13) (q10;q10) and an isochromosome (8)(q10) as the sole karyotypic abnormalities. Cancer Genet Cytogenet 118:80–82

    Article  Google Scholar 

  7. Haddadin MH, Hawkins AL, Long P, Morsberger LA, Depew D, Epstein JI, Griffin CA (2003) Cytogenetic study of malignant triton tumor: a case report. Cancer Genet Cytogenet 144:100–105

    Article  PubMed  CAS  Google Scholar 

  8. Velagaleti GV, Miettinen M, Gatalica Z (2004) Malignant peripheral nerve sheath tumor with rhabdomyoblastic differentiation (malignant triton tumor) with balanced t(7;9) (q11.2;p24) and unbalanced translocation der (16)t(1;16) (q23;q13). Cancer Genet Cytogenet 149:23–27

    Article  PubMed  Google Scholar 

  9. Magrini E, Pragliola A, Fantasia D, Calabrese G, Gaiba A, Farnedi A, Collina G, Pession A (2004) Acquisition of i(8q) as an early event in malignant triton tumors. Cancer Genet Cytogenet 2:150–155

    Article  Google Scholar 

  10. Telenius H, Carter NP, Bebb CE, Nordenskjold M, Ponder BA, Tunnacliffe A (1992) Degenerate oligonucleotide-primed PCR: general amplification of target DNA by a single degenerate primer. Genomics 13:718–725

    Article  PubMed  CAS  Google Scholar 

  11. du Manoir S, Schrock E, Bentz M, Speicher MR, Joos S, Ried T, Lichter P, Cremer T (1995) Quantitative analysis of comparative genomic hybridization. Cytometry 19:27–41

    Article  PubMed  CAS  Google Scholar 

  12. Nikitin AY, Lennartz K, Pozharisski KM, Rajewsky MF (1991) Rat model of the human “triton” tumor: direct genetic evidence for the myogenic differentiation capacity of schwannoma cells using the mutant neu gene as a cell lineage marker. Differentiation 48:33–42

    Article  PubMed  Google Scholar 

  13. Takeda O, Homma C, Maseki N, Sakurai M, Kanda N, Schwab M, Nakamura Y, Kaneko Y (1994) There may be two tumor suppressor genes on chromosome arm 1p closely associated with biologically distinct subtypes of neuroblastoma. Genes Chrom Cancer 10:30–39

    Article  PubMed  CAS  Google Scholar 

  14. Speleman F, Van Camp G, Van Roy N (1996) Reassignment of MYCL1 to human chromosome 1p34.3 by fluorescence in situ hybridization. Cytogenet Cell Genet 72:189–190

    Article  PubMed  CAS  Google Scholar 

  15. McCusick VA, Antonarakis SE, Francomano CA, Hurko O, Scott AF, Smith M, Valle D (1998) Mendelian inheritance in man: a catalog of human genes and genetic disorders, 12th edn. The Johns Hopkins University Press, Baltimore

    Google Scholar 

  16. Rylova SN, Amalfitano A, Persaud-Sawin DA, Guo WX, Chang J, Jansen PJ, Proia AD, Boustany RM (2002) The CLN3 gene is a novel molecular target for cancer drug discovery. Cancer Res 62:801–808

    PubMed  CAS  Google Scholar 

  17. Horwitz M, Benson KF, Li FQ, Wolff J, Leppert MF, Hobson L, Mangelsdorf M, Yu S, Hewett D, Richards RI, Raskind WH (1997) Genetic heterogeneity in familial acute myelogenous leukemia: evidence for a second locus at chromosome 16q21–23.2. Am J Hum Genet 61:873–881

    Article  PubMed  CAS  Google Scholar 

  18. Plaat BE, Molenaar WM, Mastik MF, Hoekstra HJ, te Meerman GJ, van den Berg E (1999) Computer assisted cytogenetic analysis of 51 malignant perpheral-nerve-sheath tumors: sporadic vs. neurofibromatosis-type-I-associated malignant schwannomas. Int J Cancer 83:171–178

    Article  PubMed  CAS  Google Scholar 

  19. Slagle BL, Zhou YZ, Butel JS (1991) Hepatitis B virus integration event in human chromosome 17p near the p53 gene identifies the region of the chromosome commonly deleted in virus-positive hepatocellular carcinomas. Cancer Res 51(1):49–54

    PubMed  CAS  Google Scholar 

  20. Hall JM, Friedman L, Guenther C, Lee MK, Weber JL, Black DM, King MC (1992) Closing in on a breast cancer gene on chromosome 17q. Am J Hum Genet 50:1235–1242

    PubMed  CAS  Google Scholar 

  21. Vahteristo P, Tamminen A, Karvinen P, Eerola H, Eklund C, Aaltonen LA, Blomqvist C, Aittomaki K, Nevanlinna H (2001) p53, CHK2, and CHK1 genes in Finnish families with Li-Fraumeni syndrome: further evidence of CHK2 in inherited cancer predisposition. Cancer Res 61:5718–5722

    PubMed  CAS  Google Scholar 

  22. Westermann F, Schwab M (2002) Genetic parameters of neuroblastomas. Cancer Lett 184(2):127–147

    Article  PubMed  CAS  Google Scholar 

  23. Liu S, Liu W, Jakubczak JL, Erexson GL, Tindall KR, Chan R, Muller WJ, Adhya S, Garges S, Merlino G (2002) Genetic instability favoring transversions associated with ErbB2-induced mammary tumorigenesis. Proc Natl Acad Sci 99:3770–3775

    Article  PubMed  CAS  Google Scholar 

  24. Romashkova JA, Makarov SS (1999) NF-kappa-B is a target of AKT in anti-apoptotic PDGF signalling. Nature 401:86–90

    Article  PubMed  CAS  Google Scholar 

  25. Gill S, Stratton MR, Patterson H, Spurr NK, Fisher C, Gusterson BA, Cooper CS (1991) Detection of transforming genes by transfection of DNA from primary soft-tissue tumours. Oncogene 6(9):1651–1656

    PubMed  CAS  Google Scholar 

  26. Lin L, Prescott MS, Zhu Z, Singh P, Chun SY, Kuick RD, Hanash SM, Orringer MB, Glover TW, Beer DG (2000) Identification and characterization of a 19q12 amplicon in esophageal adenocarcinomas reveals cyclin E as the best candidate gene for this amplicon. Cancer Res 60(24):7021–7027

    PubMed  CAS  Google Scholar 

  27. Martinerie C, Cannizzaro LA, Croce CM, Huebner K, Katzav S, Barbacid M (1990) The human VAV proto-oncogene maps to chromosome region 19p12–19p13.2. Hum Genet 86:65–68

    Article  PubMed  CAS  Google Scholar 

  28. Mathas S, Hinz M, Anagnostopoulos I, Krappmann D, Lietz A, Jundt F, Bommert K, Mechta-Grigoriou F, Stein H, Dorken B, Scheidereit C (2002) Aberrantly expressed c-Jun and JunB are a hallmark of Hodgkin lymphoma cells, stimulate proliferation and synergize with NF-kappa-B. EMBO J 21:4104–4113

    Article  PubMed  CAS  Google Scholar 

  29. Bellacosa A, de Feo D, Godwin AK, Bell DW, Cheng JQ, Altomare DA, Wan M, Dubeau L, Scambia G, Masciullo V, Ferrandina G, Benedetti Panici P, Mancuso S, Neri G, Testa JR (1995) Molecular alterations of the AKT2 oncogene in ovarian and breast carcinomas. Int J Cancer 64(4):280–285

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

This study was supported by a grant of the foundation Tumor Research Head, and Neck, Wiesbaden, Germany.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Dimitrios Koutsimpelas.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Koutsimpelas, D., Brieger, J., Heinrich, U. et al. Cytogenetic analysis of a malignant triton tumour by comparative genomic hybridization (CGH) and review of the literature. Eur Arch Otorhinolaryngol 268, 1391–1396 (2011). https://doi.org/10.1007/s00405-011-1658-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00405-011-1658-z

Keywords

Navigation